Silence Therapeutics plc·4

Jul 16, 2:58 PM ET

Griffiths Richard Ian 4

4 · Silence Therapeutics plc · Filed Jul 16, 2025

Insider Transaction Report

Form 4
Period: 2025-07-11
Transactions
  • Purchase

    American Depositary Shares

    2025-07-11+28,00011,715,365 total
    Exercise: $6.43Ordinary Shares (84,000 underlying)
  • Purchase

    American Depositary Shares

    2025-07-15+43,29311,758,658 total(indirect: See Footnote)
    Exercise: $6.40Ordinary Shares (129,879 underlying)
Footnotes (2)
  • [F1]Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.
  • [F2]The securities are held by Cream Capital Limited ("Cream"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.

Documents

1 file
  • 4
    tm2521080-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT